SVP, Finance · Maze Therapeutics, Inc. · Common Stock
Side
SELL
Value
$9,101
Shares
300
Price
$30.34
Executed
Apr 1, 2026
Disclosed
Apr 2, 2026
Disclosure timeline1 days from execution to publication · legal deadline 2 business days
Apr 1 executedApr 2, 2026 disclosed
MAZE · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 1 business day after execution (deadline: 2)
Historical behavior+1 / 15
Routine: 9 prior trades recorded in this security
Frequency & clustering+10 / 15
2 other actors traded the same direction within 14 days
Market events0 / 10
No material company filing within 60 days after the trade
Pre-arranged plan-10
Executed under a Rule 10b5-1 trading plan
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Bachrodt Amy filed this Form 4 reporting a open-market sale of MAZE on Apr 1, 2026. It became public on Apr 2, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
SVP, Finance
Bachrodt Amycik:0002050422
Issuer
Maze Therapeutics, Inc.cik:0001842295
Revision history · 0
No field has changed since this record was first ingested.
